Home LiteratureArticle Details
PMID: 15100335 Published · ppublish English Journal Article Review

Cancer stem cells: are we missing the target?

Journal of the National Cancer Institute ·Vol. 96 ·No. 8 ·2004-04-21 ·Pages 583-5

Jones RJ, Matsui WH, Smith BD

Abstract

暂无摘要

MeSH Terms
Animals Antineoplastic Agents/pharmacology Benzamides Drug Design Drug Resistance, Neoplasm Enzyme Inhibitors/pharmacology Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy,metabolism Neoplasms/drug therapy Neoplastic Stem Cells/drug effects Piperazines/pharmacology Pyrimidines/pharmacology Survival
Chemicals
Antineoplastic Agents Benzamides Enzyme Inhibitors Piperazines Pyrimidines Imatinib Mesylate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Jones Richard J
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. [email protected]
Matsui William H
Smith B Douglas
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
1460-2105
DOI
10.1093/jnci/djh095
Email
[email protected]
Published
2004-04-21
Pages
583-5
Language
English
Region
United States
NLM ID
7503089
Subset
IM
External Links
PubMed source DOI: 10.1093/jnci/djh095 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2